Ken Araki

Vice-President, Global Licensing and Business Development, Takeda Pharmaceutical Company Limited

1989, LLB, Kyushu University. Formerly: 10 years with Nomura Securities, including in Investment Banking and Global Pharmaceutical Equity Research, New York. Since 2006, with Takeda: former Head, M&A, executed acquisition of Millennium Pharmaceuticals and its integration; initiated and managed global corporate-wide strategic projects in Corporate Strategy and Planning to support senior management, including President & CEO, notably executed the acquisition of Nycomed and involved in its integration; since January 2012, responsible for global corporate development activities including M&A and also Japan Business Development group in charge of Japan/North Asia local transaction and global discovery research collaboration since January 2012.

Sobre nosostros

Eventos

Medios

Socios y Miembros

  • Únete

Ediciones en otros idiomas

Política de privacidad y normas de uso

© 2024 Foro Económico Mundial